11/20
07:06 pm
lnth
Why Lantheus Holdings Stock Won Big on Wednesday [Yahoo! Finance]
Low
Report
Why Lantheus Holdings Stock Won Big on Wednesday [Yahoo! Finance]
11/20
01:14 am
lnth
Lantheus Announces Share Repurchase Program [Yahoo! Finance]
Medium
Report
Lantheus Announces Share Repurchase Program [Yahoo! Finance]
11/20
01:00 am
lnth
Lantheus Announces Share Repurchase Program
Medium
Report
Lantheus Announces Share Repurchase Program
11/13
08:30 am
lnth
Lantheus to Present at the Jefferies London Healthcare Conference
Medium
Report
Lantheus to Present at the Jefferies London Healthcare Conference
11/13
06:22 am
lnth
Lantheus Holdings' (NASDAQ:LNTH) Promising Earnings May Rest On Soft Foundations [Yahoo! Finance]
Medium
Report
Lantheus Holdings' (NASDAQ:LNTH) Promising Earnings May Rest On Soft Foundations [Yahoo! Finance]
11/11
07:39 am
lnth
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
Medium
Report
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
11/9
08:42 am
lnth
Results: Lantheus Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]
Medium
Report
Results: Lantheus Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]
11/8
11:07 pm
lnth
Lantheus Holdings, Inc. (NASDAQ: LNTH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Lantheus Holdings, Inc. (NASDAQ: LNTH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/8
09:56 am
lnth
Lantheus Holdings, Inc. (NASDAQ: LNTH) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $120.00 price target on the stock, down previously from $135.00.
Low
Report
Lantheus Holdings, Inc. (NASDAQ: LNTH) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $120.00 price target on the stock, down previously from $135.00.
11/8
07:08 am
lnth
Lantheus Holdings Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Lantheus Holdings Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/7
04:18 pm
lnth
Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors [Yahoo! Finance]
Low
Report
Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors [Yahoo! Finance]
11/7
01:41 pm
lnth
Lantheus Holdings, Inc. (NASDAQ: LNTH) had its price target lowered by analysts at JMP Securities from $125.00 to $112.00. They now have a "market outperform" rating on the stock.
Low
Report
Lantheus Holdings, Inc. (NASDAQ: LNTH) had its price target lowered by analysts at JMP Securities from $125.00 to $112.00. They now have a "market outperform" rating on the stock.
11/7
02:19 am
lnth
Lantheus Holdings Inc (LNTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Medium
Report
Lantheus Holdings Inc (LNTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
11/6
07:00 am
lnth
Lantheus Reports Third Quarter 2024 Financial Results
High
Report
Lantheus Reports Third Quarter 2024 Financial Results
11/5
07:56 am
lnth
Lantheus Holdings Inc (LNTH) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
Low
Report
Lantheus Holdings Inc (LNTH) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
11/4
07:30 am
lnth
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
Medium
Report
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
11/1
03:40 am
lnth
Lantheus Holdings (LNTH) Achieves 22.5% Revenue Growth in Q2 2024 [Yahoo! Finance]
Low
Report
Lantheus Holdings (LNTH) Achieves 22.5% Revenue Growth in Q2 2024 [Yahoo! Finance]
10/23
08:30 am
lnth
Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time
Low
Report
Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time
10/21
03:56 pm
lnth
Lantheus: PYLARIFY's Enhanced Prospects Are Welcome, But Don't Get Too Greedy Now [Seeking Alpha]
Neutral
Report
Lantheus: PYLARIFY's Enhanced Prospects Are Welcome, But Don't Get Too Greedy Now [Seeking Alpha]
10/8
03:09 pm
lnth
Lantheus Holdings (NASDAQ:LNTH) Is Very Good At Capital Allocation [Yahoo! Finance]
Low
Report
Lantheus Holdings (NASDAQ:LNTH) Is Very Good At Capital Allocation [Yahoo! Finance]
9/25
08:02 am
lnth
Robust Quarterly Result Lifted Lantheus (LNTH) in Q2 [Yahoo! Finance]
Medium
Report
Robust Quarterly Result Lifted Lantheus (LNTH) in Q2 [Yahoo! Finance]
9/18
08:38 am
lnth
Lantheus Holdings (NASDAQ:LNTH) shareholder returns have been fantastic, earning 306% in 3 years [Yahoo! Finance]
Medium
Report
Lantheus Holdings (NASDAQ:LNTH) shareholder returns have been fantastic, earning 306% in 3 years [Yahoo! Finance]
9/15
08:54 am
lnth
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 [Yahoo! Finance]
Low
Report
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 [Yahoo! Finance]
9/15
08:45 am
lnth
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
Low
Report
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
9/10
04:36 am
lnth
Curium Announces PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer – Is Now Available in Spain [Yahoo! Finance]
Low
Report
Curium Announces PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer – Is Now Available in Spain [Yahoo! Finance]